Barbara Binzak Blumenfeld, shareholder in the firm's Life Sciences Industry Group, authored an article for Law360 entitled, “A New Era For FDA Regulation Of Cell And Tissue Products.”
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.